Literature DB >> 22587021

Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases.

Urban Švajger1, Matjaž Jeras.   

Abstract

A molecule with a relatively simple chemical structure, resveratrol has been found to interact with multiple molecular targets, many of them associated with inflammation and immunity. Indeed, it has been shown to act directly on central players of both innate and adaptive immunity, such as macrophages, lymphocytes, and dendritic cells. In addition, there is very little evidence suggesting significant deleterious side effects of resveratrol, further highlighting its potential future use as a therapeutic agent. This review provides an up-to-date discussion on recent advances regarding anti-inflammatory effects of resveratrol, mechanisms of action, and its potential for therapeutic use.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22587021     DOI: 10.3109/08830185.2012.665108

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  35 in total

1.  Resveratrol attenuates CXCL11 expression induced by proinflammatory cytokines in retinal pigment epithelial cells.

Authors:  R Krishnan Kutty; William Samuel; Rebecca Abay; Aswini Cherukuri; Chandrasekharam N Nagineni; Todd Duncan; Cynthia Jaworski; Camasamudram Vijayasarathy; T Michael Redmond
Journal:  Cytokine       Date:  2015-04-15       Impact factor: 3.861

2.  Effects of the compounds resveratrol, rutin, quercetin, and quercetin nanoemulsion on oxaliplatin-induced hepatotoxicity and neurotoxicity in mice.

Authors:  Tania E Schwingel; Caroline P Klein; Natalia F Nicoletti; Cristiana L Dora; Gabriela Hadrich; Cláudia G Bica; Tiago G Lopes; Vinicius Duval da Silva; Fernanda B Morrone
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-06-08       Impact factor: 3.000

3.  Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice.

Authors:  Dong Wang; Shi-Ping Li; Jin-Sheng Fu; Sheng Zhang; Lin Bai; Li Guo
Journal:  J Neurophysiol       Date:  2016-08-17       Impact factor: 2.714

4.  Resveratrol analogue, HS-1793, inhibits inflammatory mediator release from macrophages by interfering with the TLR4 mediated NF-κB activation.

Authors:  Wol Soon Jo; Sung Dae Kim; Soo Kyung Jeong; Su Jung Oh; Moon Taek ParK; Chang Geun Lee; Young-Rok Kang; Min Ho Jeong
Journal:  Food Sci Biotechnol       Date:  2022-03-23       Impact factor: 2.391

5.  Resveratrol protects SR-B1 levels in keratinocytes exposed to cigarette smoke.

Authors:  C Sticozzi; G Belmonte; F Cervellati; X M Muresan; F Pessina; Y Lim; H J Forman; G Valacchi
Journal:  Free Radic Biol Med       Date:  2014-01-12       Impact factor: 7.376

6.  Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule.

Authors:  Sangiliyandi Gurunathan; Jae Woong Han; Eun Su Kim; Jung Hyun Park; Jin-Hoi Kim
Journal:  Int J Nanomedicine       Date:  2015-04-15

Review 7.  Plant-derived anti-inflammatory compounds: hopes and disappointments regarding the translation of preclinical knowledge into clinical progress.

Authors:  Robert Fürst; Ilse Zündorf
Journal:  Mediators Inflamm       Date:  2014-05-29       Impact factor: 4.711

8.  Protective effects of resveratrol against UVA-induced damage in ARPE19 cells.

Authors:  Chi-Ming Chan; Cheng-Hua Huang; Hsin-Ju Li; Chien-Yu Hsiao; Ching-Chieh Su; Pei-Lan Lee; Chi-Feng Hung
Journal:  Int J Mol Sci       Date:  2015-03-12       Impact factor: 5.923

9.  Resveratrol inhibits sodium/iodide symporter gene expression and function in rat thyroid cells.

Authors:  Cesidio Giuliani; Ines Bucci; Serena Di Santo; Cosmo Rossi; Antonino Grassadonia; Marianna Mariotti; Mauro Piantelli; Fabrizio Monaco; Giorgio Napolitano
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

10.  ω-3 PUFAs and Resveratrol Differently Modulate Acute and Chronic Inflammatory Processes.

Authors:  Joseph Schwager; Nathalie Richard; Christoph Riegger; Norman Salem
Journal:  Biomed Res Int       Date:  2015-08-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.